APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Genomics Products

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Genomics Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17390729038 January 2026197 pages

Choose your research edition.

Industry ResearchGenomics Products Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Genomics Products Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Genomics Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genomics Products Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Genomics Products Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Genomics Products market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Genomics Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Genomics Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genomics Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Genomics Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Genomics Products include Zymo Research, Active Motif, Thermo Fisher Scientific, Cayman Chemical, Diagenode, Abcam, New England Biolabs, Merck & Co. and Qiagen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Genomics Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Genomics Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Genomics Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Genomics Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Genomics Products Segment by Company

Zymo Research

Active Motif

Thermo Fisher Scientific

Cayman Chemical

Diagenode

Abcam

New England Biolabs

Merck & Co.

Qiagen

Bio-Rad

Illumina

Agilent

Perkinelmer

Epizyme Inc.

CellCentric Ltd.

ValiRx plc

EpiGentek

Syndax Pharmaceuticals

Spectrum Pharmaceuticals

Promega

Novartis

Genomics Products Segment by Type

Reagents and Consumables

Bioinformatics and Software

Instruments and Systems

Others

Genomics Products Segment by Application

Pharmaceutical & Biotechnological

Companies Academic & Research Institutes Contract

Research Organizations

Others

Genomics Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genomics Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genomics Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genomics Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Genomics Products market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Genomics Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Genomics Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Genomics Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Genomics Products Industry Trends Table 2. Genomics Products Industry Drivers Table 3. Genomics Products Industry Opportunities and Challenges Table 4. Genomics Products Industry Restraints Table 5. Global Genomics Products Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Genomics Products Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Genomics Products Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Genomics Products Sales Market Share by Manufacturers Table 9. Global Genomics Products Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Genomics Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Genomics Products Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Genomics Products Manufacturers, Product Type & Application Table 13. Global Genomics Products Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Genomics Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Reagents and Consumables Table 17. Major Manufacturers of Bioinformatics and Software Table 18. Major Manufacturers of Instruments and Systems Table 19. Major Manufacturers of Others Table 20. Global Genomics Products Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Genomics Products Sales by Type (2021-2026) & (k units) Table 22. Global Genomics Products Sales by Type (2027-2032) & (k units) Table 23. Global Genomics Products Sales Market Share by Type (2021-2026) Table 24. Global Genomics Products Sales Market Share by Type (2027-2032) Table 25. Global Genomics Products Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Genomics Products Revenue by Type (2021-2026) & (k units) Table 27. Global Genomics Products Revenue by Type (2027-2032) & (k units) Table 28. Global Genomics Products Revenue Market Share by Type (2021-2026) Table 29. Global Genomics Products Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Pharmaceutical & Biotechnological Table 31. Major Manufacturers of Companies Academic & Research Institutes Contract Table 32. Major Manufacturers of Research Organizations Table 33. Major Manufacturers of Others Table 34. Global Genomics Products Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Genomics Products Sales by Application (2021-2026) & (k units) Table 36. Global Genomics Products Sales by Application (2027-2032) & (k units) Table 37. Global Genomics Products Sales Market Share by Application (2021-2026) Table 38. Global Genomics Products Sales Market Share by Application (2027-2032) Table 39. Global Genomics Products Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Genomics Products Revenue by Application (2021-2026) & (k units) Table 41. Global Genomics Products Revenue by Application (2027-2032) & (k units) Table 42. Global Genomics Products Revenue Market Share by Application (2021-2026) Table 43. Global Genomics Products Revenue Market Share by Application (2027-2032) Table 44. Global Genomics Products Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Genomics Products Sales by Region (2021-2026) & (k units) Table 46. Global Genomics Products Sales Market Share by Region (2021-2026) Table 47. Global Genomics Products Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Genomics Products Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Genomics Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Genomics Products Sales by Country (2021-2026) & (k units) Table 51. North America Genomics Products Sales by Country (2027-2032) & (k units) Table 52. Europe Genomics Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Genomics Products Sales by Country (2021-2026) & (k units) Table 54. Europe Genomics Products Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Genomics Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Genomics Products Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Genomics Products Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Genomics Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Genomics Products Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Genomics Products Sales by Country (2027-2032) & (k units) Table 61. Global Genomics Products Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Genomics Products Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Genomics Products Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Genomics Products Revenue Market Share by Region (2021-2026) Table 65. Global Genomics Products Revenue Market Share by Region (2027-2032) Table 66. Zymo Research Company Information Table 67. Zymo Research Business Overview Table 68. Zymo Research Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Zymo Research Genomics Products Product Portfolio Table 70. Zymo Research Recent Development Table 71. Active Motif Company Information Table 72. Active Motif Business Overview Table 73. Active Motif Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Active Motif Genomics Products Product Portfolio Table 75. Active Motif Recent Development Table 76. Thermo Fisher Scientific Company Information Table 77. Thermo Fisher Scientific Business Overview Table 78. Thermo Fisher Scientific Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Thermo Fisher Scientific Genomics Products Product Portfolio Table 80. Thermo Fisher Scientific Recent Development Table 81. Cayman Chemical Company Information Table 82. Cayman Chemical Business Overview Table 83. Cayman Chemical Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Cayman Chemical Genomics Products Product Portfolio Table 85. Cayman Chemical Recent Development Table 86. Diagenode Company Information Table 87. Diagenode Business Overview Table 88. Diagenode Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Diagenode Genomics Products Product Portfolio Table 90. Diagenode Recent Development Table 91. Abcam Company Information Table 92. Abcam Business Overview Table 93. Abcam Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Abcam Genomics Products Product Portfolio Table 95. Abcam Recent Development Table 96. New England Biolabs Company Information Table 97. New England Biolabs Business Overview Table 98. New England Biolabs Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. New England Biolabs Genomics Products Product Portfolio Table 100. New England Biolabs Recent Development Table 101. Merck & Co. Company Information Table 102. Merck & Co. Business Overview Table 103. Merck & Co. Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Merck & Co. Genomics Products Product Portfolio Table 105. Merck & Co. Recent Development Table 106. Qiagen Company Information Table 107. Qiagen Business Overview Table 108. Qiagen Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Qiagen Genomics Products Product Portfolio Table 110. Qiagen Recent Development Table 111. Bio-Rad Company Information Table 112. Bio-Rad Business Overview Table 113. Bio-Rad Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Bio-Rad Genomics Products Product Portfolio Table 115. Bio-Rad Recent Development Table 116. Illumina Company Information Table 117. Illumina Business Overview Table 118. Illumina Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Illumina Genomics Products Product Portfolio Table 120. Illumina Recent Development Table 121. Agilent Company Information Table 122. Agilent Business Overview Table 123. Agilent Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Agilent Genomics Products Product Portfolio Table 125. Agilent Recent Development Table 126. Perkinelmer Company Information Table 127. Perkinelmer Business Overview Table 128. Perkinelmer Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Perkinelmer Genomics Products Product Portfolio Table 130. Perkinelmer Recent Development Table 131. Epizyme Inc. Company Information Table 132. Epizyme Inc. Business Overview Table 133. Epizyme Inc. Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Epizyme Inc. Genomics Products Product Portfolio Table 135. Epizyme Inc. Recent Development Table 136. CellCentric Ltd. Company Information Table 137. CellCentric Ltd. Business Overview Table 138. CellCentric Ltd. Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. CellCentric Ltd. Genomics Products Product Portfolio Table 140. CellCentric Ltd. Recent Development Table 141. ValiRx plc Company Information Table 142. ValiRx plc Business Overview Table 143. ValiRx plc Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. ValiRx plc Genomics Products Product Portfolio Table 145. ValiRx plc Recent Development Table 146. EpiGentek Company Information Table 147. EpiGentek Business Overview Table 148. EpiGentek Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. EpiGentek Genomics Products Product Portfolio Table 150. EpiGentek Recent Development Table 151. Syndax Pharmaceuticals Company Information Table 152. Syndax Pharmaceuticals Business Overview Table 153. Syndax Pharmaceuticals Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Syndax Pharmaceuticals Genomics Products Product Portfolio Table 155. Syndax Pharmaceuticals Recent Development Table 156. Spectrum Pharmaceuticals Company Information Table 157. Spectrum Pharmaceuticals Business Overview Table 158. Spectrum Pharmaceuticals Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Spectrum Pharmaceuticals Genomics Products Product Portfolio Table 160. Spectrum Pharmaceuticals Recent Development Table 161. Promega Company Information Table 162. Promega Business Overview Table 163. Promega Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. Promega Genomics Products Product Portfolio Table 165. Promega Recent Development Table 166. Novartis Company Information Table 167. Novartis Business Overview Table 168. Novartis Genomics Products Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. Novartis Genomics Products Product Portfolio Table 170. Novartis Recent Development Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Genomics Products Distributors List Table 174. Genomics Products Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Genomics Products Product Image Figure 2. Global Genomics Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genomics Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Genomics Products Sales (2021-2032) & (k units) Figure 5. Global Genomics Products Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Genomics Products Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Reagents and Consumables Image Figure 9. Bioinformatics and Software Image Figure 10. Instruments and Systems Image Figure 11. Others Image Figure 12. Global Genomics Products Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Genomics Products Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Genomics Products Sales Market Share by Type (2021-2032) Figure 15. Global Genomics Products Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Genomics Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Genomics Products Revenue Market Share by Type (2021-2032) Figure 18. Pharmaceutical & Biotechnological Image Figure 19. Companies Academic & Research Institutes Contract Image Figure 20. Research Organizations Image Figure 21. Others Image Figure 22. Global Genomics Products Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Genomics Products Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Genomics Products Sales Market Share by Application (2021-2032) Figure 25. Global Genomics Products Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Genomics Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Genomics Products Revenue Market Share by Application (2021-2032) Figure 28. North America Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Genomics Products Sales Market Share by Country (2021-2032) Figure 30. U.S. Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Genomics Products Sales Market Share by Country (2021-2032) Figure 35. Germany Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Genomics Products Sales Market Share by Country (2021-2032) Figure 42. China Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Genomics Products Sales Market Share by Country (2021-2032) Figure 50. Brazil Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Genomics Products Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Genomics Products Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Genomics Products Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Genomics Products Revenue (2021-2032) & (US$ Million) Figure 61. North America Genomics Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Genomics Products Revenue (2021-2032) & (US$ Million) Figure 63. Europe Genomics Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Genomics Products Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Genomics Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Genomics Products Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Genomics Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Genomics Products Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Genomics Products Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Reagents and Consumables
  • Bioinformatics and Software
  • Instruments and Systems
  • Others
Applications
  • Pharmaceutical & Biotechnological
  • Companies Academic & Research Institutes Contract
  • Research Organizations
  • Others
Companies covered
  • Zymo Research
  • Active Motif
  • Thermo Fisher Scientific
  • Cayman Chemical
  • Diagenode
  • Abcam
  • New England Biolabs
  • Merck & Co.
  • Qiagen
  • Bio-Rad
  • Illumina
  • Agilent
  • Perkinelmer
  • Epizyme Inc.
  • CellCentric Ltd.
  • ValiRx plc
  • EpiGentek
  • Syndax Pharmaceuticals
  • Spectrum Pharmaceuticals
  • Promega
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Genomics Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Genomics Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Genomics Products Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Genomics Products Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Genomics Products Market Dynamics
  1. 2.1 Genomics Products Industry Trends
  2. 2.2 Genomics Products Industry Drivers
  3. 2.3 Genomics Products Industry Opportunities and Challenges
  4. 2.4 Genomics Products Industry Restraints
3 Genomics Products Market by Manufacturers
  1. 3.1 Global Genomics Products Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Genomics Products Sales by Manufacturers (2021-2026)
  3. 3.3 Global Genomics Products Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Genomics Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Genomics Products Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Genomics Products Manufacturers, Product Type & Application
  7. 3.7 Global Genomics Products Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Genomics Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Genomics Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Genomics Products Tier 1, Tier 2, and Tier 3
4 Genomics Products Market by Type
  1. 4.1 Genomics Products Type Introduction
  2. 4.1.1 Reagents and Consumables
  3. 4.1.2 Bioinformatics and Software
  4. 4.1.3 Instruments and Systems
  5. 4.1.4 Others
  6. 4.2 Global Genomics Products Sales by Type
  7. 4.2.1 Global Genomics Products Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Genomics Products Sales by Type (2021-2032)
  9. 4.2.3 Global Genomics Products Sales Market Share by Type (2021-2032)
  10. 4.3 Global Genomics Products Revenue by Type
  11. 4.3.1 Global Genomics Products Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Genomics Products Revenue by Type (2021-2032)
  13. 4.3.3 Global Genomics Products Revenue Market Share by Type (2021-2032)
5 Genomics Products Market by Application
  1. 5.1 Genomics Products Application Introduction
  2. 5.1.1 Pharmaceutical & Biotechnological
  3. 5.1.2 Companies Academic & Research Institutes Contract
  4. 5.1.3 Research Organizations
  5. 5.1.4 Others
  6. 5.2 Global Genomics Products Sales by Application
  7. 5.2.1 Global Genomics Products Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Genomics Products Sales by Application (2021-2032)
  9. 5.2.3 Global Genomics Products Sales Market Share by Application (2021-2032)
  10. 5.3 Global Genomics Products Revenue by Application
  11. 5.3.1 Global Genomics Products Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Genomics Products Revenue by Application (2021-2032)
  13. 5.3.3 Global Genomics Products Revenue Market Share by Application (2021-2032)
6 Global Genomics Products Sales by Region
  1. 6.1 Global Genomics Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Genomics Products Sales by Region (2021-2032)
  3. 6.2.1 Global Genomics Products Sales by Region (2021-2026)
  4. 6.2.2 Global Genomics Products Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Genomics Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Genomics Products Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Genomics Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Genomics Products Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Genomics Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Genomics Products Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Genomics Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Genomics Products Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Genomics Products Revenue by Region
  1. 7.1 Global Genomics Products Revenue by Region
  2. 7.1.1 Global Genomics Products Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Genomics Products Revenue by Region (2021-2026)
  4. 7.1.3 Global Genomics Products Revenue by Region (2027-2032)
  5. 7.1.4 Global Genomics Products Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Genomics Products Revenue (2021-2032)
  8. 7.2.2 North America Genomics Products Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Genomics Products Revenue (2021-2032)
  11. 7.3.2 Europe Genomics Products Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Genomics Products Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Genomics Products Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Genomics Products Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Genomics Products Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zymo Research
  2. 8.1.1 Zymo Research Company Information
  3. 8.1.2 Zymo Research Business Overview
  4. 8.1.3 Zymo Research Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zymo Research Genomics Products Product Portfolio
  6. 8.1.5 Zymo Research Recent Developments
  7. 8.2 Active Motif
  8. 8.2.1 Active Motif Company Information
  9. 8.2.2 Active Motif Business Overview
  10. 8.2.3 Active Motif Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Active Motif Genomics Products Product Portfolio
  12. 8.2.5 Active Motif Recent Developments
  13. 8.3 Thermo Fisher Scientific
  14. 8.3.1 Thermo Fisher Scientific Company Information
  15. 8.3.2 Thermo Fisher Scientific Business Overview
  16. 8.3.3 Thermo Fisher Scientific Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thermo Fisher Scientific Genomics Products Product Portfolio
  18. 8.3.5 Thermo Fisher Scientific Recent Developments
  19. 8.4 Cayman Chemical
  20. 8.4.1 Cayman Chemical Company Information
  21. 8.4.2 Cayman Chemical Business Overview
  22. 8.4.3 Cayman Chemical Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cayman Chemical Genomics Products Product Portfolio
  24. 8.4.5 Cayman Chemical Recent Developments
  25. 8.5 Diagenode
  26. 8.5.1 Diagenode Company Information
  27. 8.5.2 Diagenode Business Overview
  28. 8.5.3 Diagenode Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Diagenode Genomics Products Product Portfolio
  30. 8.5.5 Diagenode Recent Developments
  31. 8.6 Abcam
  32. 8.6.1 Abcam Company Information
  33. 8.6.2 Abcam Business Overview
  34. 8.6.3 Abcam Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Abcam Genomics Products Product Portfolio
  36. 8.6.5 Abcam Recent Developments
  37. 8.7 New England Biolabs
  38. 8.7.1 New England Biolabs Company Information
  39. 8.7.2 New England Biolabs Business Overview
  40. 8.7.3 New England Biolabs Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 New England Biolabs Genomics Products Product Portfolio
  42. 8.7.5 New England Biolabs Recent Developments
  43. 8.8 Merck & Co.
  44. 8.8.1 Merck & Co. Company Information
  45. 8.8.2 Merck & Co. Business Overview
  46. 8.8.3 Merck & Co. Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck & Co. Genomics Products Product Portfolio
  48. 8.8.5 Merck & Co. Recent Developments
  49. 8.9 Qiagen
  50. 8.9.1 Qiagen Company Information
  51. 8.9.2 Qiagen Business Overview
  52. 8.9.3 Qiagen Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Qiagen Genomics Products Product Portfolio
  54. 8.9.5 Qiagen Recent Developments
  55. 8.10 Bio-Rad
  56. 8.10.1 Bio-Rad Company Information
  57. 8.10.2 Bio-Rad Business Overview
  58. 8.10.3 Bio-Rad Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bio-Rad Genomics Products Product Portfolio
  60. 8.10.5 Bio-Rad Recent Developments
  61. 8.11 Illumina
  62. 8.11.1 Illumina Company Information
  63. 8.11.2 Illumina Business Overview
  64. 8.11.3 Illumina Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Illumina Genomics Products Product Portfolio
  66. 8.11.5 Illumina Recent Developments
  67. 8.12 Agilent
  68. 8.12.1 Agilent Company Information
  69. 8.12.2 Agilent Business Overview
  70. 8.12.3 Agilent Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Agilent Genomics Products Product Portfolio
  72. 8.12.5 Agilent Recent Developments
  73. 8.13 Perkinelmer
  74. 8.13.1 Perkinelmer Company Information
  75. 8.13.2 Perkinelmer Business Overview
  76. 8.13.3 Perkinelmer Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Perkinelmer Genomics Products Product Portfolio
  78. 8.13.5 Perkinelmer Recent Developments
  79. 8.14 Epizyme Inc.
  80. 8.14.1 Epizyme Inc. Company Information
  81. 8.14.2 Epizyme Inc. Business Overview
  82. 8.14.3 Epizyme Inc. Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Epizyme Inc. Genomics Products Product Portfolio
  84. 8.14.5 Epizyme Inc. Recent Developments
  85. 8.15 CellCentric Ltd.
  86. 8.15.1 CellCentric Ltd. Company Information
  87. 8.15.2 CellCentric Ltd. Business Overview
  88. 8.15.3 CellCentric Ltd. Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CellCentric Ltd. Genomics Products Product Portfolio
  90. 8.15.5 CellCentric Ltd. Recent Developments
  91. 8.16 ValiRx plc
  92. 8.16.1 ValiRx plc Company Information
  93. 8.16.2 ValiRx plc Business Overview
  94. 8.16.3 ValiRx plc Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 ValiRx plc Genomics Products Product Portfolio
  96. 8.16.5 ValiRx plc Recent Developments
  97. 8.17 EpiGentek
  98. 8.17.1 EpiGentek Company Information
  99. 8.17.2 EpiGentek Business Overview
  100. 8.17.3 EpiGentek Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 EpiGentek Genomics Products Product Portfolio
  102. 8.17.5 EpiGentek Recent Developments
  103. 8.18 Syndax Pharmaceuticals
  104. 8.18.1 Syndax Pharmaceuticals Company Information
  105. 8.18.2 Syndax Pharmaceuticals Business Overview
  106. 8.18.3 Syndax Pharmaceuticals Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Syndax Pharmaceuticals Genomics Products Product Portfolio
  108. 8.18.5 Syndax Pharmaceuticals Recent Developments
  109. 8.19 Spectrum Pharmaceuticals
  110. 8.19.1 Spectrum Pharmaceuticals Company Information
  111. 8.19.2 Spectrum Pharmaceuticals Business Overview
  112. 8.19.3 Spectrum Pharmaceuticals Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Spectrum Pharmaceuticals Genomics Products Product Portfolio
  114. 8.19.5 Spectrum Pharmaceuticals Recent Developments
  115. 8.20 Promega
  116. 8.20.1 Promega Company Information
  117. 8.20.2 Promega Business Overview
  118. 8.20.3 Promega Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Promega Genomics Products Product Portfolio
  120. 8.20.5 Promega Recent Developments
  121. 8.21 Novartis
  122. 8.21.1 Novartis Company Information
  123. 8.21.2 Novartis Business Overview
  124. 8.21.3 Novartis Genomics Products Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Novartis Genomics Products Product Portfolio
  126. 8.21.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Genomics Products Value Chain Analysis
  2. 9.1.1 Genomics Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Genomics Products Production Mode & Process
  6. 9.2 Genomics Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Genomics Products Distributors
  9. 9.2.3 Genomics Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst